期刊文献+

血清HE4、CYFRA21—1、CA199在诊断卵巢良、恶性肿瘤中的价值 被引量:9

Value of serum HE4, CYFRA21-1, CA199 in the diagnosis of ovarian benign and malignant tumor
原文传递
导出
摘要 目的 探讨血清人附睾蛋白4(HE4)、细胞角蛋白19片段(CYFRA211)、糖类抗原199(CA199)对卵巢恶性肿瘤诊断的意义,评价其单独及联合检测在判断卵巢癌高风险中的价值。方法 采用电化学发光免疫法(ECL)检测威海市妇幼保健院就诊的45例原发性卵巢癌、56例良性卵巢肿瘤患者及50例健康体检女性血清中HE4、CYFRA211、CA199水平,分析三者在卵巢癌诊断中的阳性率及符合率,比较3种指标对卵巢肿瘤的诊断价值。结果 血清HE4在恶性肿瘤组与良性肿瘤组之间、恶性肿瘤组与对照组之间差异均有统计学意义(Z=-8.61,P<0.001;Z=-8.39,P<0.001);CYFRA211在恶性肿瘤组与良性肿瘤组之间,恶性肿瘤组与对照组差异有统计学意义(Z=-8.60,P<0.001;Z=-8.39,P<0.001),HE4、CYRA211良性肿瘤组与对照组比较差异无统计学意义(Z=-1.31,P=0.189; Z=-1.29,P=0.191);CA199在良性肿瘤组与对照组比较差异有统计学意义(Z=-8.79,P<0.001),对于恶性肿瘤两者诊断的特异性和阳性预测值都很高(HE4为99.8%、99.7%, CYFRA211为99.0%、96.7%),HE4、CYFRA211诊断的符合率也比较高,分别为93.4%、88.7%,但两者的敏感性比CA199低。CA199在卵巢良、恶性肿瘤中都会升高,只是升高的程度不同,但对卵巢癌诊断的特异性不是很高(85.8%),阳性预测值和诊断符合率也比较低(70.6%、84.1%),三者联合检测则可以提高卵巢癌诊断的敏感性(100%)及准确性(89.4%)。结论 HE4、CYFRA211只在恶性卵巢肿瘤中升高,主要用于卵巢癌的诊断;CA199在良、恶性卵巢肿瘤中都有升高,但升高的程度不同,可用于良、恶性肿瘤的诊断与鉴别,三者联合检测则可提高卵巢癌诊断的敏感性和准确率,对于卵巢癌的早期诊断与治疗监测有重要的意义。 ObjectiveTo investigate the diagnosis significance of human epididymis (HE4), cytokeratin19fragment (CYFRA211), carbohydrate antigen 199 (CA199) on the malignant ovarian tumor, and to evaluate the value of individual and combined detection in judging high risk ovarian cancer. MethodsThe serum HE4, CYFRA211, CA199 levels of 45 patients with primary ovarian cancer, 56 patients with benign ovarian tumor and 50 healthy checkup women in our hospital were detected by electrochemiluminescence immunoassay (ECL).The positive rates and coincidence rates of them were analyzed and the diagnostic value of them were compared.ResultsHE4 and CYFRA211 levels of ovarian cancer group were significantly higher compared with the benign tumor group and healthy control group and the differences were statistically significant (Z=-8.61,P〈0.001;Z=-8.39,P〈0.001; Z=-8.60,P〈0.001;Z=-8.39,P〈0.001), however there is no difference between benign tumor group andcontrol group(Z=-1.31,P=0.189; Z=-1.29,P=0.191). The difference of CA199 between benign tumor group and control group was statistically significant (Z=-8.79,P〈0.001).For the malignant tumors, the specificity and positive predictive value of HE4 (99.8%, 99.7%), CYFRA211 (99.0%, 96.7%) were very high and the diagnostic accordance rates were relatively high (93.4%, 88.7%), but the sensibilities of them were lower compared with CA199.CA199 was increased both in benign and malignant ovarian tumors with different degrees, but the specificity was not very high (85.8%), and the positive predictive value and the diagnosis accordance rate were low (70.6%, 84.1%). The combined detection of HE4, CYFRA 211 and CA199 could improve the sensitivity and of the diagnosis of ovarian cancer (100%) and accuracy (89.4%).ConclusionsHE4 and CYFRA211 only increas in malignant ovarian tumors, and they are mainly used for the diagnosis of ovarian cancer; CA199 level is increased both in benign and malignant ovarian tumors,
出处 《国际肿瘤学杂志》 CAS 2015年第9期657-660,共4页 Journal of International Oncology
关键词 卵巢肿瘤 角蛋白质类 抗原 肿瘤相关 碳水化合物 人附睾蛋白4 Ovarian neoplasms Keratins Antigens, tumor-associated, carbohydrate human epididymis protein 4
  • 相关文献

参考文献11

  • 1Oberaigner W, Minicozzi P, Bielska-Lasota M,et al. Survial for ovari- an cancer in Europe: the across-country did not shrink in the past dec- ade[J]. Acta Oneol, 2012, 51(4) :441-453. 被引量:1
  • 2Moore RG, MaeLanghlan S, Bast Re Jr. Current state of biomarket de- velopment for clinical application in epithelial ovarian cancer [Jl. Gy- neeol Oncol, 2010, 116(2) :240-245. 被引量:1
  • 3Havrilesky LJ, Whitehead CM, Rubatt JM, et al. Evaluation of bio- marker panels for early stage ovarian cancer detection and monitoring for disease recurrence[ J]. Gynecol Oncol, 2008, 110(3 ) :374-382. 被引量:1
  • 4Karolina P, Bjorg K J, Karin S, et al. Evaluation of ovarian cancer bi- omarkers HE4 and CA-125 in women presenting with a suspicious cyst- ic ovarian mass[J]. J Gynecol Oneol, 2011, 22(4) :244-252. 被引量:1
  • 5Brechot JM, Chevret S, Natal" J, et al. Diagnostic and prognostic value of Cyfra 21-1 compared with other tumor markers in patients with non- small lung cancer: a prospective study of 116 patients [J]. Eur J Cancer, 1997, 33(3) :385-391. 被引量:1
  • 6Kawai M, Kano T, Kikkawa F, et al. Seven tumor markers in benign and malignant germ cell tumors of the ovary [ Jl. Gynecol Oncol, 1992, 45(3) :248-253. 被引量:1
  • 7Fioretti P, Gaddueci A, Ferdeghini M, et al. The concomitant deter- mination of different serum tumor markers in epithelial ovarian cancer: relewanee for monitoring the response to chemotherapy and follow-up of patients[J]. Gyneeol Oneol, 1992, 44(2) :155-160. 被引量:1
  • 8Moll R, Franke WW, Schiler D L, et al. The catalog of human eytok- eratins:patterns of expression in normal epithelial,tumors and cultured cells[J]. Cell, 1982, 31(1) :11-24. 被引量:1
  • 9Galgano MT, Hampton GM, Frierson HF Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues [ J ]. Mod Pathol, 2006, 19(6) :847-853. 被引量:1
  • 10Wang K, Gan L, Jeffrey E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA nficroarray [ J ]. Gene, 1999, 299(1-2) :101-108. 被引量:1

同被引文献81

引证文献9

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部